• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较玻璃体内曲安奈德治疗伴有与不伴有浆液性视网膜脱离的分支型视网膜静脉阻塞的囊样黄斑水肿的疗效:对视敏度和形态的影响。

Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.

机构信息

Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, 477-96, Owada-shinden, Yachiyo, Chiba 276-8524, Japan.

出版信息

BMC Ophthalmol. 2012 Aug 9;12:39. doi: 10.1186/1471-2415-12-39.

DOI:10.1186/1471-2415-12-39
PMID:22876931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3532084/
Abstract

BACKGROUND

The influence of serous retinal detachment (SRD) on visual acuity, macular sensitivity, and macular thickness is unclear after intravitreal injection of triamcinolone acetonide (IVTA) for macular edema with branch retinal vein occlusion (BRVO).

METHODS

Twenty-one eyes of 21 BRVO patients with macular edema received IVTA. Patients were divided into two groups by optical coherence tomography findings: 11 patients who had cystoid macular edema (CME) with SRD (SRD (+) group) and 10 patients who had CME without SRD (SRD (-) group). Microperimetry was performed with a Micro Perimeter 1 before and at 3 and 6 months after IVTA. Macular thickness was measured by optical coherence tomography. We exchanged the superior and inferior regions to separate the regions into those with and without occlusion. As a result, the superior region was always the occluded region and the inferior region was non-occluded.

RESULTS

In both the SRD (-) group and the SRD (+) group, the mean macular thickness within the central 4° field and the 10° and 20° fields of the occluded region decreased significantly from baseline to 3 and 6 months after IVTA (all P <0.01). Visual acuity also improved significantly in both groups from baseline to 3 and 6 months after IVTA (both P <0.05). In both groups, the mean macular sensitivity (measured with by microperimetry) within the central 4° field and the 10° and 20° fields of the occluded region showed a significant increase from baseline to 3 and 6 months after IVTA (all P <0.05). The trend profiles of macular thickness within the 10° and 20° fields of the occluded region showed significant differences, but there were no significant differences with respect to the trend profiles of visual acuity and macular sensitivity within the central 4° field and the 10° and 20° fields of the occluded region.

CONCLUSIONS

These results suggest that IVTA may achieve more marked improvement of macular morphology in BRVO patients with SRD than in those without SRD, while this therapy may have a similar effect on macular function in BRVO patients with or without SRD.

摘要

背景

在伴有分支静脉阻塞(BRVO)的黄斑水肿患者中,玻璃体内注射曲安奈德(IVTA)后,视网膜脱离(SRD)对视力、黄斑敏感性和黄斑厚度的影响尚不清楚。

方法

21 例 BRVO 伴黄斑水肿患者的 21 只眼接受 IVTA 治疗。根据光学相干断层扫描(OCT)结果将患者分为两组:11 例合并 SRD 的患者(SRD(+)组)和 10 例无 SRD 的患者(SRD(-)组)。在 IVTA 前、3 个月和 6 个月时使用微视野计进行微视野检查。通过 OCT 测量黄斑厚度。我们交换上下区域,将区域分为闭塞区和非闭塞区。结果,上区域始终是闭塞区,下区域是非闭塞区。

结果

在 SRD(-)组和 SRD(+)组中,闭塞区中央 4°和 10°、20°区域的黄斑平均厚度均从基线至 IVTA 后 3 个月和 6 个月显著降低(均 P<0.01)。两组视力均从基线至 IVTA 后 3 个月和 6 个月显著提高(均 P<0.05)。两组患者的闭塞区中央 4°和 10°、20°区域的黄斑平均敏感度(微视野计测量)均从基线至 IVTA 后 3 个月和 6 个月显著升高(均 P<0.05)。虽然闭塞区 10°和 20°区域的黄斑厚度趋势曲线存在显著差异,但在中央 4°区域和闭塞区 10°和 20°区域的视力和黄斑敏感度的趋势曲线无显著差异。

结论

这些结果表明,IVTA 可能会使伴有 SRD 的 BRVO 患者的黄斑形态改善更为显著,而对伴有或不伴有 SRD 的 BRVO 患者的黄斑功能可能具有相似的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b6/3532084/3e072225c32c/1471-2415-12-39-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b6/3532084/aa0bc1a04158/1471-2415-12-39-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b6/3532084/51500f4344f9/1471-2415-12-39-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b6/3532084/3e072225c32c/1471-2415-12-39-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b6/3532084/aa0bc1a04158/1471-2415-12-39-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b6/3532084/51500f4344f9/1471-2415-12-39-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26b6/3532084/3e072225c32c/1471-2415-12-39-3.jpg

相似文献

1
Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.比较玻璃体内曲安奈德治疗伴有与不伴有浆液性视网膜脱离的分支型视网膜静脉阻塞的囊样黄斑水肿的疗效:对视敏度和形态的影响。
BMC Ophthalmol. 2012 Aug 9;12:39. doi: 10.1186/1471-2415-12-39.
2
Visual function and serous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series.患者分支静脉阻塞伴黄斑水肿的视功能与浆液性视网膜脱离:病例系列。
BMC Ophthalmol. 2011 Sep 26;11:29. doi: 10.1186/1471-2415-11-29.
3
Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion.玻璃体内曲安奈德注射治疗视网膜分支静脉阻塞继发黄斑水肿的视网膜敏感性改善。
Indian J Ophthalmol. 2013 Jan-Feb;61(1):3-7. doi: 10.4103/0301-4738.105048.
4
[Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].[早期玻璃体腔内注射曲安奈德(IVTA)与延迟注射治疗视网膜静脉阻塞所致黄斑水肿的疗效比较]
J Fr Ophtalmol. 2011 Jun;34(6):355-61. doi: 10.1016/j.jfo.2011.04.008. Epub 2011 Jun 8.
5
Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜分支静脉阻塞患者后浆液性黄斑脱离的消退情况
Retina. 2005 Oct-Nov;25(7):856-60. doi: 10.1097/00006982-200510000-00007.
6
Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜中央静脉阻塞所致的浆液性黄斑脱离。
Retina. 2007 Oct;27(8):1026-30. doi: 10.1097/IAE.0b013e3180645905.
7
Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.曲安奈德玻璃体腔内注射治疗视网膜静脉分支阻塞伴黄斑水肿的功能形态学改变。
J Ocul Pharmacol Ther. 2012 Jun;28(3):231-6. doi: 10.1089/jop.2011.0137. Epub 2012 Feb 3.
8
Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.曲安奈德和贝伐单抗玻璃体腔注射治疗视网膜分支静脉阻塞所致黄斑水肿的前瞻性比较。
Acta Ophthalmol. 2013 Jun;91(4):318-24. doi: 10.1111/j.1755-3768.2011.02298.x. Epub 2011 Dec 1.
9
Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema.弥漫性糖尿病性黄斑水肿患者玻璃体内曲安奈德的视觉结果取决于光相干断层扫描模式。
Retina. 2011 Apr;31(4):748-54. doi: 10.1097/IAE.0b013e3181f04991.
10
Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion.曲安奈德玻璃体腔内注射治疗视网膜静脉分支阻塞伴黄斑水肿后的黄斑敏感性和形态。
Retina. 2012 Oct;32(9):1844-52. doi: 10.1097/IAE.0b013e318259569f.

引用本文的文献

1
Biochemical and microstructural determinants of the development of serous retinal detachment secondary to retinal vein occlusion.视网膜静脉阻塞继发浆液性视网膜脱离发展的生化和微观结构决定因素
Heliyon. 2023 Dec 16;10(1):e23716. doi: 10.1016/j.heliyon.2023.e23716. eCollection 2024 Jan 15.
2
Treatment strategy for BVO-ME based on long-term outcomes correlating retinal structure by OCT image and visual acuity.基于 OCT 图像视网膜结构和视力相关的长期结果的 BVO-ME 治疗策略。
BMC Ophthalmol. 2023 Sep 20;23(1):385. doi: 10.1186/s12886-023-03138-2.
3
A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion.

本文引用的文献

1
Visual function and serous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series.患者分支静脉阻塞伴黄斑水肿的视功能与浆液性视网膜脱离:病例系列。
BMC Ophthalmol. 2011 Sep 26;11:29. doi: 10.1186/1471-2415-11-29.
2
Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusion.玻璃体积血的炎症因子与分支视网膜静脉阻塞的浆液性黄斑脱离。
Retina. 2012 Jan;32(1):86-91. doi: 10.1097/IAE.0b013e31821801de.
3
Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema.
一项关于分支视网膜静脉阻塞继发黄斑水肿的真实世界证据管理的系统评价。
Eye (Lond). 2020 Oct;34(10):1770-1796. doi: 10.1038/s41433-020-0861-9. Epub 2020 Apr 20.
4
Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion.玻璃体内注射兰尼单抗治疗视网膜分支静脉阻塞所致浆液性视网膜脱离的疗效
Clin Ophthalmol. 2018 Aug 17;12:1465-1470. doi: 10.2147/OPTH.S162019. eCollection 2018.
5
Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis.内源性皮质醇水平与中心性浆液性脉络膜视网膜病变风险的关联:一项Meta分析。
Int J Ophthalmol. 2018 Feb 18;11(2):296-300. doi: 10.18240/ijo.2018.02.19. eCollection 2018.
6
Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion.视网膜分支静脉阻塞患者玻璃体内注射一针曲安奈德治疗后黄斑水肿消退的相关因素。
J Int Med Res. 2016 Jun;44(3):685-97. doi: 10.1177/0300060515617386. Epub 2016 Mar 1.
伴有黄斑水肿的视网膜分支静脉阻塞患者的功能形态相关性。
Retina. 2011 Nov;31(10):2102-8. doi: 10.1097/IAE.0b013e318212e24d.
4
Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.视网膜分支静脉阻塞伴黄斑水肿患者的可溶性血管内皮生长因子受体-2 和炎症因子。
Am J Ophthalmol. 2011 Oct;152(4):669-677.e1. doi: 10.1016/j.ajo.2011.04.006. Epub 2011 Jul 2.
5
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.雷珠单抗治疗视网膜分支静脉阻塞继发黄斑水肿的持续获益:一项 III 期研究的 12 个月结果。
Ophthalmology. 2011 Aug;118(8):1594-602. doi: 10.1016/j.ophtha.2011.02.022.
6
Serous retinal detachment associated with retinal vein occlusion.与视网膜静脉阻塞相关的浆液性视网膜脱离。
Am J Ophthalmol. 2010 Feb;149(2):291-301.e5. doi: 10.1016/j.ajo.2009.09.007.
7
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.一项比较玻璃体内注射曲安奈德与标准治疗方案治疗视网膜分支静脉阻塞继发黄斑水肿所致视力丧失的疗效和安全性的随机试验:视网膜静脉阻塞的标准治疗与皮质类固醇治疗(SCORE)研究报告6
Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233.
8
Hypertension and hyperlipidemia management in patients treated at community health centers.社区卫生中心治疗患者的高血压和高脂血症管理
J Clin Outcomes Manag. 2008;15(3):125-131.
9
Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜静脉阻塞继发黄斑水肿后的视网膜敏感性
Retina. 2009 Jun;29(6):757-67. doi: 10.1097/IAE.0b013e31819d4fbf.
10
Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.曲安奈德对视网膜分支静脉阻塞中血管内皮生长因子和紧密连接蛋白水平的影响
Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. doi: 10.1016/j.ajo.2008.12.006. Epub 2009 Feb 10.